Aug 01, 2019 XOMA Congratulates Rezolute on its Successful Financing and Progress Towards Initiating Phase 2b Study for RZ358
Jun 07, 2019 XOMA Congratulates Iscalimab Anti-CD40 Antibody Development Program on its Early Clinical Successes
Nov 5, 2019 • 8:20 AM EST XOMA Reports Third Quarter 2019 Royalty Asset Portfolio Highlights and Financial Results
Sep 26, 2019 • 8:27 AM EDT XOMA to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
